News - Blue Horizon International

Blue Horizon International does not offer or provide medical treatment or see patients within the United States. Our cellular and exosome products are investigational and are not approved by the U.S. FDA. This website is for informational and educational purposes only and is not medical advice.

Style Sampler

Layout Style

Patterns for Boxed Mode

Backgrounds for Boxed Mode

Categories
- News
- Research

News

Home
News

BHI Therapeutic Sciences And Mehling Orthopedics to attend American Academy Of Orthopaedic Surgeons Annual Meeting in San Francisco

Feb 08, 2024 by BHI

No Comments

Brian Mehling, M.D. orthopedic trauma surgeon and stem cell researcher, is scheduled to attend and exhibit at the 2024 Annual Meeting of the American Academy of Orthopaedic Surgeons in San Francisco, CA from February 12-16, 2024 at the Moscone Center, [...]

View post

Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation

Jan 11, 2024 by BHI

No Comments

Note: The following references or summarizes published, peer-reviewed scientific literature and is provided for educational and informational purposes only. It is not a claim that any product is safe or effective, has not been evaluated by the FDA, and is [...]

View post

Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation – Before Author’s Corrections

Jan 11, 2024 by BHI

No Comments

Note: The following references or summarizes published, peer-reviewed scientific literature and is provided for educational and informational purposes only. It is not a claim that any product is safe or effective, has not been evaluated by the FDA, and is [...]

View post

Stem Cell Evaluation of Immune response to Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation

Jan 11, 2024 by BHI

No Comments

Note: The following references or summarizes published, peer-reviewed scientific literature and is provided for educational and informational purposes only. It is not a claim that any product is safe or effective, has not been evaluated by the FDA, and is [...]

View post

Allogeneic umbilical cord blood mononuclear cell therapy for spinal cord injury – a retrospective cohort study

Jan 11, 2024 by BHI

No Comments

Note: The following references or summarizes published, peer-reviewed scientific literature and is provided for educational and informational purposes only. It is not a claim that any product is safe or effective, has not been evaluated by the FDA, and is [...]

View post

A Retrospective Study of Stromal Vascular Fraction Cell Therapy for Osteoarthritis

Jan 11, 2024 by BHI

No Comments

Note: The following references or summarizes published, peer-reviewed scientific literature and is provided for educational and informational purposes only. It is not a claim that any product is safe or effective, has not been evaluated by the FDA, and is [...]

View post

Safety study of cultured human Wharton’s Jelly mesenchymal stem cell therapy for multiple indications – a retrospective descriptive study

Jan 11, 2024 by BHI

No Comments

Note: The following references or summarizes published, peer-reviewed scientific literature and is provided for educational and informational purposes only. It is not a claim that any product is safe or effective, has not been evaluated by the FDA, and is [...]

View post

Brian Mehling, MD of Mehling Orthopedics Named NJ Top Doc For 2023

Jun 15, 2023 by BHI

No Comments

NJ Top Docs has reviewed and approved Brian Mehling, MD of Mehling Orthopedics for 2023. Dr. Brian Mehling is a board-certified orthopedic trauma surgeon specializing in regenerative medicine. He is also board certified by the American Academy of Anti-Aging Medicine. [...]

View post

Pavel Yufit, MD of Mehling Orthopedics Named NJ Top Doc For 2023

Jun 15, 2023 by BHI

No Comments

NJ Top Docs has reviewed and approved Pavel Yufit, MD of Mehling Orthopedics for 2023. Dr. Pavel Yufit is a board-certified orthopedic surgeon specializing in trauma treatment. He has been practicing medicine for over 15 years. Always a stellar student, [...]

View post

NJ Top Docs 2022, Dr, Brian Mehling and Dr. Pavel Yufit Specialize in Trauma Treatment

May 19, 2022 by BHI

No Comments

NJ Top Docs has reviewed and approved board-certified orthopedic surgeons, Brian Mehling, MD and Pavel Yufit, MD of Mehling Orthopedics for 2022. Both are fellows of the American Academy of Orthopedic Surgeons and specialize in trauma treatment. They are also [...]

View post

1
2
3
›
»

About Blue Horizon International

Blue Horizon International is a healthcare-management and research organization focused on advancing scientific research and education in regenerative medicine. We collaborate with academic and clinical partners, including affiliations with university research institutions, and our affiliates operate in accordance with the applicable regulatory requirements of the jurisdictions in which they are licensed. Our cellular and exosome products are investigational and are not approved by the U.S. FDA.

The statements on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Our cellular and exosome products are investigational, are not FDA-approved, and are not intended to diagnose, treat, cure, or prevent any disease. The information provided here is for educational purposes only and is not medical advice.